Graybug Vision, Inc.
Justin Hanes is the founder of Theraly, Inc., Theraly Diabetes, Inc., and GrayBug, LLC. Justin is also a founder and former director of Kala Pharmaceuticals. Currently, Justin serves as the Lewis J. Ort Professor at the Wilmer Eye Institute at Johns Hopkins University. Hanes holds a Ph.D. in Chemical Engineering from Massachusetts Institute of Technology and a BS in Chemical Engineering from UCLA.
This person is not in any teams
Graybug Vision, Inc.
Graybug is a biopharmaceutical company focused on developing transformative medicines for ocular diseases. Founded in 2011 based on technology licensed from the Johns Hopkins University School of Medicine, Graybug has offices in Redwood City, California and Baltimore, Maryland. For more information, please visit www.graybug.vision.